The Health Policy Partnership named as finalist in Communiqué Awards 2023

24 May 2023


The Health Policy Partnership is thrilled to be a finalist in the Communiqué Awards 2023, a prestigious series of awards that celebrate excellence in the healthcare communications and public affairs industry. HPP is a finalist for Public Affairs and Policy Consultancy of the Year, while two of our projects are finalists for Excellence in Communicating and Using Data. These nominations pertain to the work we conducted in 2022.

HPP is delighted to have been shortlisted for the tightly contested Public Affairs and Policy Consultancy of the Year category. This nomination recognises our expertise and achievements as an organisation, putting people at the heart of everything we do.

Co-founder and Managing Director Suzanne Wait said: ‘We have come such a long way as an organisation and 2022 was really the year where it felt like our vision for what we wanted the company to become came together. This nomination is a credit to the entire team who have contributed to the company’s growth, tested and perfected our processes and ways of working as we developed them, and cemented trust among those who work with us. I’m incredibly proud!’

Co-founder and Managing Director Ed Harding said: ‘We are a highly professional and commercially successful consultancy, but what really defines us is the trust and respect we have earned from a wide range of stakeholders. It has been such a privilege to work with some of the leading patient and clinical leaders in their fields on multiple topics – and to be told that our work has helped them drive meaningful change.’

We also have two projects in the running for the category of Excellence in Communicating and Using Data. First, our global database of lung cancer screening is the first comprehensive tool that showcases clinical trials, implementation studies and existing programmes for low-dose computed tomography (LDCT) screening for lung cancer around the world. It offers an interactive database with heat maps and other visualisation of data.

We developed the interactive map as part of our role as Secretariat to the Lung Cancer Policy Network. The map’s format and contents were built with close insights and guidance from the Network’s members. It now serves as a living, global resource bringing together information about 133 initiatives from 38 countries, and is updated on a regular basis. It enables those working in lung cancer screening to draw lessons from implementation around the world, and allows advocates for screening to showcase real-world data on screening implementation, helping them make the case for investment in lung cancer screening programmes with their respective governments.

Our second nomination in this category is for our work on assessing readiness for radioligand therapy in the UK. Radioligand therapy is an innovative approach available to treat several types of cancer. This project sought to fill a critical gap in knowledge, as the therapy was little known among healthcare professionals and the public. We saw the importance of scaling up understanding of and capacity for this type of treatment, and worked with health system leaders to understand the changes required.

As part of this work, we developed a peer-reviewed Readiness Assessment Framework with support from a multidisciplinary advisory group, and conducted qualitative and quantitative research to identify new data and insights from a wide range of stakeholders. This work has already increased awareness of radioligand therapy in the UK and contributed to initial action among clinical societies and regulators, including changes to guidelines and regulations.

The Communiqué Awards 2023 winners will be announced on 6 July 2023.